1. Patients with synchronous or metachronous diagnosis of resectable liver metastases by computed tomography (CT) or magnetic resonance imaging (MRI) of the abdomen: a) Patients requiring percutaneous or intraoperative ablation of liver metastases < 2 cm in size are eligible. b) Patients who underwent prior liver resection or ablation for colorectal liver metastases are eligible.